These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11594225)

  • 1. [Development of an organotypic corneal construction as an in vitro model for permeability studies].
    Reichl S; Müller-Goymann CC
    Ophthalmologe; 2001 Sep; 98(9):853-8. PubMed ID: 11594225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reconstruction of an in vitro cornea and its use for drug permeation studies from different formulations containing pilocarpine hydrochloride.
    Tegtmeyer S; Papantoniou I; Müller-Goymann CC
    Eur J Pharm Biopharm; 2001 Mar; 51(2):119-25. PubMed ID: 11226818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human corneal equivalent as cell culture model for in vitro drug permeation studies.
    Reichl S; Bednarz J; Müller-Goymann CC
    Br J Ophthalmol; 2004 Apr; 88(4):560-5. PubMed ID: 15031177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of a porcine organotypic cornea construct for permeation studies from formulations containing befunolol hydrochloride.
    Reichl S; Müller-Goymann CC
    Int J Pharm; 2003 Jan; 250(1):191-201. PubMed ID: 12480285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human cornea construct HCC-an alternative for in vitro permeation studies? A comparison with human donor corneas.
    Reichl S; Döhring S; Bednarz J; Müller-Goymann CC
    Eur J Pharm Biopharm; 2005 Jul; 60(2):305-8. PubMed ID: 15939241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Esterase activity of human organotypic cornea construct (HCC) as in vitro model for permeation studies].
    Meyer L; Bednarz J; Müller-Goymann CC; Reichl S
    Ophthalmologe; 2005 Oct; 102(10):971-80. PubMed ID: 15785910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cultivation and characterization of a bovine in vitro model of the cornea.
    Tegtmeyer S; Reichl S; Müller-Goymann CC
    Pharmazie; 2004 Jun; 59(6):464-71. PubMed ID: 15248462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular drug permeation following experimental excimer laser treatment on the isolated pig eye.
    Scholz M; Schründer S; Gärtner S; Keipert S; Hartmann C; Pleyer U
    J Ocul Pharmacol Ther; 2002 Apr; 18(2):177-83. PubMed ID: 12002670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of alpha-cyclodextrin and hydroxyalkylated beta-cyclodextrin derivatives on the in vitro corneal uptake and permeation of aqueous pilocarpine-HCl solutions.
    Siefert B; Keipert S
    J Pharm Sci; 1997 Jun; 86(6):716-20. PubMed ID: 9188054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Theoretical corneal permeation model for ionizable drugs.
    Friedrich SW; Cheng YL; Saville BA
    J Ocul Pharmacol; 1993; 9(3):229-49. PubMed ID: 8228531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell culture models of the human cornea - a comparative evaluation of their usefulness to determine ocular drug absorption in-vitro.
    Reichl S
    J Pharm Pharmacol; 2008 Mar; 60(3):299-307. PubMed ID: 18284809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a serum-free human cornea construct for in vitro drug absorption studies: the influence of varying cultivation parameters on barrier characteristics.
    Hahne M; Reichl S
    Int J Pharm; 2011 Sep; 416(1):268-79. PubMed ID: 21771646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of corneal permeation of riboflavin-5'-phosphate through vitamin E TPGS: a promising approach in corneal trans-epithelial cross linking treatment.
    Ostacolo C; Caruso C; Tronino D; Troisi S; Laneri S; Pacente L; Del Prete A; Sacchi A
    Int J Pharm; 2013 Jan; 440(2):148-53. PubMed ID: 23046664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a convenient ex vivo model for the study of the transcorneal permeation of drugs: histological and permeability evaluation.
    Pescina S; Govoni P; Potenza A; Padula C; Santi P; Nicoli S
    J Pharm Sci; 2015 Jan; 104(1):63-71. PubMed ID: 25394188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro permeation characteristics of moxifloxacin from oil drops through excised goat, sheep, buffalo and rabbit corneas.
    Pawar PK; Majumdar DK
    Pharmazie; 2007 Nov; 62(11):853-7. PubMed ID: 18065102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro cell culture models to study the corneal drug absorption.
    Reichl S; Kölln C; Hahne M; Verstraelen J
    Expert Opin Drug Metab Toxicol; 2011 May; 7(5):559-78. PubMed ID: 21381983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidrug resistance-associated protein (MRP1, 2, 4 and 5) expression in human corneal cell culture models and animal corneal tissue.
    Verstraelen J; Reichl S
    Mol Pharm; 2014 Jul; 11(7):2160-71. PubMed ID: 24456047
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    De Hoon I; Boukherroub R; De Smedt SC; Szunerits S; Sauvage F
    Mol Pharm; 2023 Jul; 20(7):3298-3319. PubMed ID: 37314950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of transcorneal permeation of pilocarpine.
    Mitra AK; Mikkelson TJ
    J Pharm Sci; 1988 Sep; 77(9):771-5. PubMed ID: 3225772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanistic studies on transcorneal permeation of pilocarpine.
    Sieg JW; Robinson JR
    J Pharm Sci; 1976 Dec; 65(12):1816-22. PubMed ID: 1032669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.